IRIS
GHIORZO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.559
AS - Asia 168
SA - Sud America 39
NA - Nord America 12
Totale 21.778
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 21.556
CN - Cina 123
BR - Brasile 32
VN - Vietnam 26
SG - Singapore 15
US - Stati Uniti d'America 9
AR - Argentina 3
CO - Colombia 2
MX - Messico 2
RU - Federazione Russa 2
CL - Cile 1
EC - Ecuador 1
FR - Francia 1
HK - Hong Kong 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
SV - El Salvador 1
Totale 21.778
Salva come PNG Salva come JPEG
Città #
Genova 12.035
Genoa 6.081
Rapallo 1.921
Vado Ligure 1.471
Beijing 50
Bordighera 46
Ho Chi Minh City 14
Ashburn 8
Singapore 6
Hanoi 3
São Paulo 3
Brasília 2
Curitiba 2
Haiphong 2
Rome 2
Aurora 1
Avellaneda 1
Baghdad 1
Barra do Piraí 1
Benito Juarez 1
Buenos Aires 1
Buon Ma Thuot 1
Bắc Ninh 1
Campo Grande 1
Campos dos Goytacazes 1
Cao Lanh 1
Caxias do Sul 1
Central de Minas 1
Colombo 1
Diamantina 1
Eṭ Ṭaiyiba 1
Filadélfia 1
Formosa 1
Goiânia 1
Guayaquil 1
Hong Kong 1
Hưng Yên 1
Itumbiara 1
Ituzaingó 1
Jundiaí 1
Kizlyar 1
Maipú 1
Manaus 1
Mexicali 1
Nashville 1
Quảng Ngãi 1
Rio de Janeiro 1
Salvador 1
San Salvador 1
Santa Luzia 1
Santa Marta 1
Serra 1
São Bernardo do Campo 1
São José dos Campos 1
São José dos Pinhais 1
São Miguel do Guaporé 1
São Vicente 1
Teixeira de Freitas 1
Thái Nguyên 1
Tokyo 1
Tây Ninh 1
Villa de Leyva 1
Viçosa 1
Zhengzhou 1
Totale 21.695
Salva come PNG Salva come JPEG
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 215
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients 203
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer 196
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 190
An upstream positive regulatory element in human GM-CSF promoter is recognized by NF-kB/Rel family members 186
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. 186
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 185
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 181
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 179
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 179
Incidence of other neoplasia in Italian melanoma-prone families with p16 (GLy93Trp) mutation 178
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 178
Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation of OBFC1 177
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma 171
The effect on melanoma risk of genes previously associated with telomere length. 170
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 170
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 170
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup 169
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 168
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 167
Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma 166
c-Rel and p65 subunits bind to an upstream NF-kB site in human granulocyte macrophage-colony stimulating factor promoter involved in phorbol ester response in 5637 cells 165
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma 164
A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds 163
Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project 161
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 161
Association of Genetic Variants in CDK6 and XRCC1 with the Risk of Dysplastic Nevi in Melanoma-Prone Families. 160
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLDmutation in Brenner tumor 160
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: A pooled-analysis from the M-SKIP project. 160
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 158
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 158
Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant 158
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL) 156
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. 155
Identification, genetic testing, and management of hereditary melanoma 153
PCCR: Pancreatic Cancer Collaborative Registry. 152
Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene 151
Gly101Trp germline mutation in the CDKN2A gene in familial and non familial Ligurian melanoma patients 150
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents 146
Alcohol and Tobacco Lower the Age of Presentation in Sporadic Pancreatic Cancer in a Dose-Dependent Manner: A Multicenter Study. 146
Molecular characterization of an Italian series of sporadic GISTs. 144
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 144
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 141
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 141
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 141
Mutational concordance between primary and metastatic melanoma: A next-generation sequencing approach 141
Genome-wide association study identifies three new melanoma susceptibility loci 140
Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma. 139
A variant in FTO shows association with melanoma risk not due to BMI. 137
Genetic testing for melanoma 136
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 136
Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer 136
Meta-analysis combining new and existing data sets confirms that the TERT-CLPTM1L locus influences melanoma risk. 135
Signs and genetics of rare cancer syndromes with gastroenterological features 134
The CDKN2A/p16INK4a 5'UTR sequence and translational regulation: Impact of novel variants predisposing to melanoma 134
MelaNostrum: A Consensus Questionnaire of Standardized Epidemiologic and Clinical Variables for Melanoma Risk Assessment by the MelaNostrum Consortium 134
Coexisting NRAS and BRAF Mutations in Primary Familial Melanomas with Specific CDKN2A Germline Alterations. 133
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma 133
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 133
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 133
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL 132
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT 132
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. 129
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 129
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 127
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 127
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding 127
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study. 127
Analysis of p16 protein expression in familial melanoma patients: correlation with germline status. 126
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations 126
Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development 126
Cell-type–specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes 126
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study 125
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 125
The 5′-untranslated region of p16INK4a acts as a cellular IRES, controls mRNA translation during hypoxic and energetic stresses, and is a target of YBX1 124
High prevalence of the G101W germline mutation in the CDKN2A (P16INK4A) gene in 62 Italian malignant melanoma families 124
High prevalence of the Gly101Trp germline mutation in the CDKN2A gene in 62 small Italian families 123
Linkage Analysis in melanoma prone families 123
Mutation screening of the CDKN2A promoter melanoma families 123
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 123
Genetic predisposition to pancreatic cancer. 122
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma 122
Identification of a SUFU germline mutation in a family with Gorlin syndrome 121
Common sequence variants on 20q11.22 confer melanoma susceptibility 121
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma 120
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma 120
Hereditary trichilemmal cysts: A proposal for the assessment of diagnostic clinical criteria 120
Italian Melanoma-prone Families:Germline mutational analysis and Clinical-Epidemiological Characterization 119
Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families 119
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma 118
CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment 118
Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients 118
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma from Liguria 117
Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies 117
Impact of novel CDKN2A/p16INK4a 5’UTR variants predisposing to melanoma on p16 translational regulation 117
Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls 117
Characterization of Ligurian Melanoma families and risk of occurence of other neoplasia 116
Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family. 116
Ink4/ARF germline mutations and additional neoplasia in pancretic cancer patients and their families 115
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma from Liguria 115
Totale 14.398
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.368
article - articoli 67.497
book - libri 0
conference - conferenze 9.880
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 991
Totale 156.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021962 0 0 0 0 71 114 86 113 136 170 129 143
2021/20222.200 94 174 130 244 90 169 166 495 94 209 83 252
2022/20232.338 269 153 25 235 430 362 17 187 385 16 217 42
2023/20241.268 52 153 20 139 76 205 96 76 97 36 76 242
2024/20253.762 121 266 150 275 472 365 402 601 170 172 300 468
2025/20262.463 734 260 888 563 18 0 0 0 0 0 0 0
Totale 22.285